Browsing publications by Professor Olaf Heidenreich

Newcastle AuthorsTitleYear
Dr Andrea Beyerle
Hesta McNeill
Professor Olaf Heidenreich
A Definition of the Molecular Parameters for the Formation of Transfection-Effective siRNA-Cell-Penetrating Peptide Nanoparticles2013
Dr Klaus Rehe
Kerrie Wilson
Dr Simon Bomken
Dr Daniel Williamson
Dr Julie Irving
et al.		Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations2013
Dr Simon Bomken
Dr Lars Buechler
Dr Klaus Rehe
Dr Frida Ponthan
Dr Alex Elder
et al.		Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression2013
Dr Andrea Beyerle
Professor Olaf Heidenreich
Dr James Allan
AML1/ETO Confers a Mutator Phenotype in AML2012
Professor Olaf Heidenreich
Depletion of RUNX1/ETO in t(8:21) AML cells leads to genome-wide changes in transcription factor binding2012
Dr Daniel Williamson
Hesta McNeill
Dr Michael Cullen
Professor Bryan Young
Professor Olaf Heidenreich
et al.		Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding2012
Dr Alex Elder
Professor Olaf Heidenreich
Professor Josef Vormoor
Lentiviralmarking as a tool to investigate the clonal complexity and evolution of ALL2012
Dr Andrea Beyerle
Professor Olaf Heidenreich
Dr James Allan
AML1/ETO Confers a Mutator Phenotype In Acute Myeloid Leukemia Associated with Downregulation of the Base-Excision-Repair Gene OGG12011
Dr Klaus Rehe
Professor Olaf Heidenreich
Professor Josef Vormoor
Beth Gibson
Central Nervous System Involvement in a Xenograft Model of Pre-B Acute Lymphoblastic Leukaemia Is Associated with Dysfunctional CXCR4 Expression and Upregulation of the Neurotropic Chemokine Receptors CCR6 and CX3CR12011
Professor Olaf Heidenreich
Effective and specific control of aml1/eto gene expression in acute myeloid leukemia cells by lentivector-based RNA-interference2011
12345678910